Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The legislation would amend the Public Health Service Act, ERISA, and the Internal Revenue Code so that any cost‑sharing requirement for a prescription drug cannot be higher than the nationwide average price paid by consumers. It would affect health‑insurance plans, employers offering coverage, and individuals who pay out‑of‑pocket for medicines. The goal is to prevent unusually high copays or coinsurance that exceed what most consumers actually pay.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 10133 changes status, plus AI-powered summaries and stage predictions.
Sign up free